Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans

NCT01590277 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT01590277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01590277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans
Lead sponsor
VA Office of Research and Development
Phase
Phase 1
Overall status
Completed
Start date
December 14, 2012
Completion date
November 2, 2018
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

active ethanol and active iomazenil, active ethanol and placebo iomazenil, alcohol effect, alcohol impairment, driving under the influence, placebo ethanol and active iomazenil, placebo ethanol and placebo iomazenil